December 10, 2020 Ror1 delivers its second takeout in five weeks Boehringer Ingelheim buys NBE-Therapeutics, the second Ror1-focused player to be taken out in just over a month.
December 09, 2020 Ash 2020 movers – shorts roasting on an open fire IGM’s snowballing share price belies some other major Ash winners, and will make Christmas unhappy for funds that had shorted the stock.
November 06, 2020 Ash 2020 preview – early winners and losers Unveiling of abstracts for December’s haematology meeting sent Crispr up and Allogene down, but the biggest beneficiary was private.